Chargement en cours...
Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement
Histological evidence of benign prostatic hyperplasia (BPH) exceeded 50% in men over 50 years of age and rose to 75% as men entered the eighth decade. Therapeutic options for BPH generally fall into one of the three categories: watchful waiting, medical treatment and surgery. Excluding watchful wait...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Carol Davila University Press
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3019017/ https://ncbi.nlm.nih.gov/pubmed/20108746 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|